StockNews.com Initiates Coverage on Aeterna Zentaris (NASDAQ:AEZS)
StockNews.com began coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Get Rating) (TSE:AEZ) in a research note issued to investors on Sunday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reiterated a buy rating and set a $28.00 price target on shares of Aeterna Zentaris in a research report […]